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I would like to discuss the development and his-
torical aspects of cardiac pacemaking from a personal 
point of view, presented as it appeared to me over the 
yef1rS. This approach is biased, selective, and incom-
plete, but I think as informative as I can make it. 
It has long been known, indeed from the early days 
of Galvani, that electrical currents have effects on the 
heart. The knowledge that a cardiac contraction may 
result from an electrical stimulus led to no clinically 
useful result until relatively recently Other instances 
are common perhaps even at the present time in 
medicine in which basic information is available for 
advances in therapy but is not being used. 
There was not much change in this field until about 
1900, when a great deal of research was conducted on 
the effects of electrical currents on the heart. It was 
demonstrated in physiological and pharmacological 
laboratories then that electrical stimuli produced action 
currents that were conducted along nerve or muscle 
cells, and produced contractions in skeletal, smooth, 
and cardiac muscle. Among the important contributors 
were Adrian, Evans, and John Erlanger In 1900, 
Prevost and Batelli demonstrated that electrical cur-
rents, both direct-current and alternating-current dis-
charges, would terminate ventricular fibrillation. The 
shocks were applied directly to the heart, but it took 
a very long time again before this information was 
used effectively In 1933, Hooker, Kouwenhoven, and 
Langworthy made extensive and valuable laboratory 
studies on the effects of alternating current in termi-
nating ventricular fibrillation, again the current was 
applied directly to the exposed heart. This work was 
extended in 1936 by Ferris, King, Spence, and Wil-
liams, who demonstrated that capacitor discharges 
also terminated ventricular fibrillation. They used 
sheep, relatively large animals, with hearts similar to 
man's in size, but again information lay dormant 
without human, clinical application. In 1946, some 
Russian workers, Gurvich and Yuniev, recorded very 
briefly in the English literature that capacitor dis-
charges would terminate ventricular fibrillation. About 
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1940, Wiggers and Wegria conducted extensive ex-
perimental studies outlining the various features of 
electric shock that were useful in terminating ven-
tricular fibrillation. Wiggers demonstrated that an 
initial alternating-current shock might produce ven-
tricular fibrillation in a normally beating heart and a 
second shock of the same nature but perhaps a little 
stronger might terminate the fibrillation. Wiggers ap-
plied the term "countershock" to this procedure, 
which I like to use and keep alive despite current usage 
of other terms because of its historical significance. 
I think we should give him credit for providing us 
with the sound experimental basis for the technique 
of defibrillation which has saved so many lives. The 
first clinically successful termination of ventricular 
fibrillation in man was done in 1947 by Beck, Pritch-
ard, and Feil, who resuscitated a patient from ven-
tricular fibrillation by performing emergency thoraco-
tomy, direct cardiac "massage," and application of 
alternating current to the exposed heart. In this very 
brief review of direct ventricular defibrillation, I have 
passed over some instances in 1902 and 1910 of 
defibrillation that were unsuccessful. In 1947, Claude 
Beck and his group in Cleveland had established that 
opening the chest and applying a-c countershock would 
terminate ventricular fibrillation, this procedure formed 
the basis for the treatment of cardiac arrest that was 
widely taught and vigorously practiced in those days. 
In the presence of cardiac arrest, under any circum-
stances one was supposed to cut the chest open, 
"massage," i.e. squeeze the heart rhythmically to 
provide an effective output, and if necessary to de-
fibrillate the heart by direct application of alternating-
current countershocks. 
In 1932, Dr Albert S. Hyman in New York City 
addressed himself to the parallel problem of ven-
tricular standstill. He attempted to develop an effective 
means of stimulating the heart in ventricular standstill 
so as to terminate cardiac arrest. He applied a stimulus 
from an electric pacemaker to the atrium by passing 
a long needle or electrode through the chest wall into 
the atrial musculature. He demonstrated effective 
atrial stimulation in the rabbit by this technique, but 
it was never applied successfully in man as far as I 
know A major difficulty lay in the maintenance of 
good contact of the needle electrode in the cardiac 
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muscle without displacement or injury Another prob-
lem was in the application of the stimulus to the 
atrium, in clinical cardiac arrest atrioventricular block 
is often present so that atrial beats are not conducted 
and do not arouse ventricular contractions. 
In their extensive studies in 1940, Wiggers and 
Wegria examined the effects of electric stimuli of 
varying intensity and duration at varying intervals after 
a preceding beat, and clearly delineated the various 
phases of cardiac excitability They demonstrated and 
applied the term "vulnerable phase" to the interval 
in the relative refractory period when a strong (well 
above threshold for a single response) or Jong stimulus 
produces multiple or repetitive beats and even fibril-
lation. The stimuli used in these studies were 10 milli-
seconds long, whereas present-day pacemakers provide 
stimuli usually less than 2 milliseconds long. This ex-
plains why they were able to demonstrate repetitive 
responses and the vulnerable period so readily 
I became interested in electric stimulation of the 
heart shortly after World War II, after I had observed 
much of the pioneering cardiac surgery done by Dr 
Dwight Harken for the removal of foreign bodies 
in and about the heart. The heart appeared, indeed, 
to be a very sensitive organ that responded readily 
with ventricular contractions to stimuli, arousal from 
ventricular standstill by appropriate stimulation should, 
therefore, not be difficult. The other point with which 
I was impressed I should have learned in first-year 
anatomy-the esophagus lies behind the heart in very 
close contact with it. Thoracotomy and direct electrical 
stimulation of the heart seemed to be an inappro-
priate and excessively traumatic approach to the prob-
lem of effective cardiac stimulation that was not much 
better than the universally accepted program of thora-
cotomy, cardiac massage, and direct countershock 
defibrillation. It seemed to me that a stimulus might 
arouse a ventricular contraction in a patient with 
cardiac arrest if it were applied in the esophagus close 
to the heart by way of a long wire electrode passed 
down the mouth. 
I thought about this matter for some time but did 
not do much about it, I am afraid, for a long while. 
My background in electricity was inadequate, so I 
did not know how to build a pacemaker that would 
provide an appropriate stimulus. In 1950, William C. 
Callaghan, a Canadian cardiac surgeon, spoke at a 
Boston Surgical Society meeting and described an ap-
proach of passing a wire electrode "catheter" down 
the jugular vein in a dog, and stimulating the area 
of the sine-atrial node to provide an effective rhythm 
controlled by an external pacemaker This method 
has not been used clinically but it is very interesting 
and it contains elements of many of our present-day 
techniques, especially the idea of applying an electric 
stimulus by way of a pervenous endocardial "catheter" 
wire electrode. He made a great effort to apply it to the 
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sine-atrial node, not an appropriate site for ordinary 
clinical purposes in patients with A-V block, but one 
that is being reconsidered for special purposes now 
I found that he used a standard physiologic pacemaker 
made by the Grass Instrument Company in Quincy, 
Mass., and within the next year I managed to borrow 
one from Dr Otto Krayer, head of the Pharmacology 
department of the Harvard Medical School. With a 
long wire electrode in the esophagus and a second 
electrode over the precordium in a dog, I was quickly 
able to demonstrate that electrical stimuli would indeed 
arouse atrial or ventricular electrical responses and 
effective muscular contractions with which cardiac 
arrest could be terminated and the circulation main-
tained. An extensive laboratory study was undertaken 
to develop the details of this new technique of external 
electric stimulation of the heart, to improve and 
simplify the procedure and the apparatus, to define its 
clinical applicability and limitations, and to expose 
any associated hazards. It was soon found that rather 
large currents were necessary for effective stimulation 
(30 to 150 volts or 50 to 200 milliamperes) unless the 
negative electrode actually touched the heart, and that 
two surface electrodes on each side of the precordium 
were as effective as an esophageal-precordial pair 
Short stimuli, 2-3 milliseconds in duration, were 
selected when they were found to be almost as ef-
fective as longer ones in stimulating single responses 
and never produced repetitive responses, tachycardia, 
or fibrillation except in hearts seriously damaged by 
ischemia, anoxia, or overdoses of digitalis or quinidine. 
In 1952, we applied the method of external electric 
stimulation for the first time in man, and it quickly 
became established as an effective emergency means 
of arousing the heart from ventricular standstill. Al-
though most frequently used in patients with Stokes-
Adams disease, it was also effective in standstill of 
any origin, even in the absence of A-V block, so long 
as cardiac contractility was not overly depressed by 
prolonged anoxia or drugs. Although external stimu-
lation was occasionally used in desperate circum-
stances for hours or days to maintain an artificial 
rhythm, it proved too painful for ordinary long-term 
use. For the purposes of arousing, accelerating, and 
maintaining intrinsic ventricular rhythms in patients 
with high-degree A-V block, Dr Arthur J Linenthal 
and I developed the method of intravenous administra-
tion of dilute solutions of sympathomimetic amines, 
particularly epinephrine and isoproterenol. Combined 
use of the two methods often enabled us to keep pa-
tients alive through intervals of severely unstable 
rhythm and frequent Stokes-Adams attacks. 
We also found at that time that provision of a rapid 
regular rhythm by external electric stimulation or by 
acceleration of an intrinsic pacemaker pharmacologi-
cally would often stop recurrent ventricular tachy-
cardia and fibrillation. This demonstration lies behind 
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the concept of overdriving the heart to suppress multi-
ple competing rhythmic foci, which is an important 
aspect of present-day control of cardiac rhythm with 
electric pacemakers. 
The method of external electric cardiac stimulation 
is based on the idea of applying a large electric cur-
rent to the surface of the chest so that a small portion 
of it may reach the heart and stimulate a response, 
just as a small electric stimulus applied directly to the 
exposed heart was known to do. The success of this 
technique suggested modification of the usual counter-
shock defibrillation after thoracotomy by application of 
a large countershock externally across the surface of 
the chest. In 1954, contemporaneously with William 
Kouwenhoven at Johns Hopkins and Arthur C. Guy-
ton at the University of Mississippi, we developed a 
technique for external electric countershock defibril-
lation with large 60-cycle alternating-current shocks 
in dogs and domestic pigs. The next year we applied 
it successfully for the first time to resuscitate a patient 
from ventricular fibrillation. We also demonstrated in 
the laboratory that external a-c countershock would 
terminate every type of rapid arrhythmia. atrial tachy-
cardia, atrial fibrillation, ventricular tachycardia, and 
ventricular fibrillation. In 1955, we terminated several 
desperate attacks of ventricular tachycardia and in 
1957 one of atrial tachycardia in man with external 
a-c countershock. In 1961, Bernard Lown at the Peter 
Bent Brigham Hospital greatly modified this approach 
by applying external direct-current shocks ( obtained 
by capacitor discharge through an inductance) that 
were synchronized to fall immediately after the R 
wave so as to avoid the vulnerable phase of the cardiac 
cycle. He used this method, which he termed "cardi-
oversion," for the elective termination of lesser ar-
rhythmias with the thought that synchronization would 
prevent the production of ventricular fibrillation. Al-
though some disagreement with this view persists 
(from myself and other workers as well), the tech-
nique of synchronized d-c shock is most generally 
used today The initial enthusiasm for cardioversion 
of minor arrhythmias has subsided considerably be-
cause of the frequent early recurrence of the ar-
rhythmia with little clinical benefit. 
The development of these two methods of external 
electric stimulation and of external electric counter-
shock led to great changes in the management of 
cardiac arrest. With effective emergency means of 
arousal of the heart from standstill and of defibrilla-
tion without the need for thoracotomy, programs of 
action became simpler, less traumatic, and more 
successful. The unpredictability of attacks and the 
limited time available for resuscitation pointed to the 
need for prompt recognition of the onset of arrest and 
identification of the arrhythmia. From our early ex-
periences with patients with Stokes-Adams disease 
came the development of cardiac monitors in 1954 
that provide an audible signal of each beat, continuous 
visual display of the electrocardiogram, an alarm signal 
of appropriate changes in rate, and prompt, even 
automatic availability of an external electric pace-
maker In 1960, William Kouwenhoven developed the 
technique of "external cardiac massage," or external 
cardiac compression, by which circulation of blood 
may be restored immediately in the emergency of 
cardiac arrest and, if necessary, the time interval for 
more definitive management of arrhythmia may be 
extended. 
In 1963, Hughes Day combined all these techniques 
and applied them to patients with acute myocardial 
infarction, the largest group with serious arrhythmias. 
He placed patients with this condition under con-
tinuous monitoring in a coronary care unit where 
monitors, pacemakers, and defibrillators were concen-
trated together with personnel expert in their use and 
trained in a program for management of cardiac arrest. 
His demonstration in the pioneer unit at Bethany, 
Kansas, of a major reduction in mortality from acute 
myocardial infarction led to the widespread acceptance 
of the concept of the coronary care unit. 
It seems unfortunate to me, however, that the idea 
of continuous cardiac monitoring has not been applied 
widely to surgical operating rooms where unexpected 
cardiac arrest still occurs with significant frequency 
and mortality In 1963, Drs. Morris Nicholson and 
Joseph Crehan, anesthesiologists at the New England 
Deaconness Hospital in Boston, monitored a number 
of very sick patients throughout anesthesia. In this 
group they demonstrated a striking improvement in 
successful resuscitation from cardiac arrest. Despite 
this convincing experience, continuous cardiac moni-
toring with automatic alarm has not become a 
standard part of the management of all patients under-
going anesthesia, as I believe it should. 
The final subject of discussion is the development 
of internal cardiac pacemakers for the long-term pro-
vision of a reliable rhythm at any rate desired. The 
need for a method of prolonged cardiac stimulation 
was obvious early in our experience with patients 
with Stokes-Adams disease, when we were able to 
resuscitate patients from attacks of standstill or fibril-
lation but were unable to prevent recurrent episodes. 
Direct cardiac pacing with small, imperceptible elec-
tric stimuli by means of electrodes implanted in the 
myocardium had long been known and used experi-
mentally, but for years long-term pacing in this way 
was frustrated by a progressive rise in threshold for 
stimulation. In 1958, Thevenet, Hodges, and Lillehei 
in Minneapolis attempted to stimulate the heart 
directly in patients with Stokes-Adams disease with 
a stainless-steel electrode placed in the myocardium 
at thoracotomy that was connected to an externally 
carried pulse generator Stimulation failed uniformly 
within 7 weeks, however, because of increasing thres-
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hold for cardiac response. We finally recognized the 
problem as a foreign-body tissue reaction to minute, 
sterile contaminants on the electrode surface and 
solved it by using inert metals for the active electrode 
(platinum, gold, or stainless steel) and by boiling it 
in Ivory soap flakes. Dr Samuel A. Hunter in St. 
Paul developed the Hunter-Roth electrode and with 
it was the first in 1959 to achieve long-term pacing 
in a patient with Stokes-Adams disease. In 1960, 
Drs. William Chardack, Adrian Kantrowitz, and 
Howard Frank and I began series of implantations of 
pacemaker-electrode systems by way of thoracotomy, 
and adequate long-term management of A-V block 
and Stokes-Adams disease was finally accomplished. 
Many problems arose and many changes were made 
in long-term cardiac pacing to meet them. Displace-
ment of electrodes, wire breakage, and component 
failure in the pulse generator have in large measure 
been corrected, but early battery depletion remains 
the major difficulty at present. An important modifica-
tion, which has become widely accepted, has been in 
the placement of a pervenous endocardial "catheter" 
electrode under fluoroscopic control rather than by 
thoracotomy This approach was first introduced by 
Drs. Seymour Furman and John Schwede! at the 
Montefiore Hospital in New York City with the elec-
trode passed through an antecubital vein and con-
nected to an externally carried pulse generator Sub-
sequently, other veins were used and the entire 
pacemaker system was placed subcutaneously Al-
though the procedure is relatively minor, it is not 
entirely satisfactory in that electrode placement is 
sometimes very difficult and even unsuccessful, and 
electrode displacement, myocardial perforation, high 
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threshold for stimulation, and wire breakage occur 
with small but significant frequency In this regard, 
we have recently developed an "arrowhead" electrode 
that may be inserted rather quickly and securely 
through a small thoracotomy but under direct vision. 
This technique is an attempt to gain the advantages 
of both approaches-secure placement of the electrode 
in the myocardium but with a relatively small, well-
tolerated procedure. 
In recent years, many types of pacemakers have 
been developed to avoid competition of an independent 
fixed-rate pulse generator with intrinsic beats, which do 
occur often from ectopic ventricular foci or from 
return of A-V conduction. It appears that competi-
tion offers little risk clinically of repetitive response 
and ventricular fibrillation, unless an electrode is 
inserted in an area of acute myocardial ischemia or 
infarction. Nevertheless, variable-rate ("synchronous," 
"demand," or "stand-by") pacemakers may at times 
be advantageous in producing less palpitation and 
better cardiac output. Atrial-triggered, ventricular-
triggered and inhibited, and atrial-ventricular sequen-
tial pulse generators of many varieties have been de-
veloped, and some are now being widely used. 
Presently, both temporary and long-term pacing 
are also being applied with considerable enthusiasm 
in a variety of clinical situations and to a wide variety 
of difficult arrhythmias. Consequently, the area of 
applicability of cardiac pacing is growing. Advances 
in technology and engineering also promise major im-
provements in new generations of pacemakers so that 
we can anticipate exciting developments in the whole 
field of electrical control of cardiac rhythm. 
